Women more likely to take part in clinical trials they discover through peers

March 10, 2017, Taylor & Francis

Women are often underrepresented in HIV clinical trials, making it difficult to decipher the relevance of findings and whether they are applicable to all.

Coinciding with National Women and Girls HIV/AIDS Awareness Day, new data published today in the Taylor & Francis journal HIV Clinical Trials uncovers how an evidence-based campaign, Follow YOUR Heart, is empowering older women with HIV to participate in a large-scale clinical trial aimed at preventing cardiovascular disease, the REPRIEVE trial.

Massachusetts General Hospital and Harvard Medical School researchers Dr Sara Looby and Dr. Markella Zanni uncovered women's preferred methods for learning about a trial were peer-to-peer communication (52% of those questioned), provider communication (46%) and video-based communication (39%). Women were most likely to take part to gain information (63%) and to help others (47%).

Dr. Looby and Dr. Zanni commented: "Feedback from our community sample of women offered valuable perspectives on methods to help educate and engage women with HIV on research participation, making our Follow YOUR Heart campaign truly patient-centered."

Explore further: Better health for women involved in clinical trials

More information: Markella V. Zanni et al. Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trial, HIV Clinical Trials (2017). DOI: 10.1080/15284336.2017.1297551

Related Stories

Better health for women involved in clinical trials

February 14, 2017
Women who participate in obstetric and gynaecology clinical trials experience improved health outcomes compared to those who are not involved in trials, according to research by Queen Mary University of London (QMUL). This ...

Most women feel PCPs are involved in breast cancer care

October 10, 2016
(HealthDay)—Most women newly diagnosed with breast cancer perceive high primary care provider (PCP) quality, and report that their PCPs have high engagement and communication, according to research published online Oct. ...

Regrets? Opting out of clinical trials may prompt more than a few

May 20, 2015
Women who choose not to participate in a clinical trial may be significantly more likely to later regret that decision than women who choose to participate in the study, according to a team of Penn State researchers.

Results from the PLATINUM DIVERSITY study presented

November 1, 2016
A dedicated stent study conducted exclusively in women and minority patients evaluated clinical outcomes within the era of contemporary PCI, comparing these results to a parallel cohort of white male patients. Although there ...

Major clinical trial led to steep declines in use of an ineffective breast cancer treatment

July 7, 2016
Many common medical treatments have never been tested in a clinical trial. A new study published in the July issue of Health Affairs highlights how evidence from trials of untested but widely used treatments can change medical ...

Type 2 diabetes drug trials unnecessarily exclude women

May 5, 2016
While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal harm, according to Penn ...

Recommended for you

New simulation tool predicts how well HIV-prophylaxis will work

June 14, 2018
A new mathematical simulation approach predicts the efficacy of pre- and post-exposure prophylaxis (PrEP) medications, which help prevent HIV infection. The framework, presented in PLOS Computational Biology by Sulav Duwal ...

Many at risk for HIV despite lifesaving pill

June 11, 2018
Multiple barriers may stop high-risk individuals from accessing an HIV drug that can reduce the subsequent risk of infection, according to a new University of Michigan study.

Active HIV in large white blood cells may drive cognitive impairment in infected mice

June 7, 2018
Macrophages, large white blood cells that engulf and destroy potential pathogens, harbor active viral reserves that appear to play a key role in impaired learning and memory in mice infected with a rodent version of HIV. ...

HIV vaccine elicits antibodies in animals that neutralize dozens of HIV strains

June 4, 2018
An experimental vaccine regimen based on the structure of a vulnerable site on HIV elicited antibodies in mice, guinea pigs and monkeys that neutralize dozens of HIV strains from around the world. The findings were reported ...

HIV study reveals new group of men at risk of infection

June 4, 2018
A group of men who may be underestimating their HIV risk has been identified in a new study.

Discovery reveals how cells try to control levels of key HIV protein

May 31, 2018
One of the many challenges in treating HIV is that the virus can lie dormant in cells, quietly evading immune detection until it suddenly roars to life without warning and begins replicating furiously. Salk Institute researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.